What is RGEN (RGEN) stock price today?

RGEN (RGEN) is currently trading at $131.06, down 0.68% today.

What is RGEN P/E ratio?

RGEN's P/E ratio is 145.51. This is above the market average, reflecting high growth expectations.

What is RGEN return on equity (ROE)?

RGEN's return on equity (ROE) is 2.51%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is RGEN's market cap?

RGEN has a market capitalization of $7.39B.

NASDAQ · Medical - Instruments & Supplies

RGEN (RGEN) Stock

$131.06 -0.68% NASDAQ: RGEN Healthcare

Valuation

Metric	Value
Price	$131.06
Market Cap	$7.39B
P/E Ratio	145.51
P/B Ratio	3.55
P/S Ratio	9.79
EPS (TTM)	$0.86
52-Week High	$175.77
52-Week Low	$100.99
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	2.51%
ROA	1.18%
ROCE	2.85%
Gross Margin	50.25%
Operating Margin	8.81%
Net Margin	6.73%
Debt/Equity	0.33
Current Ratio	8.36

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$671.0M	$802.0M	$632.0M	$634.0M	$738.0M
Operating Profit	$167.0M	$225.0M	$48.0M	$-35.0M	$60.0M
Net Profit	$128.0M	$186.0M	$36.0M	$-26.0M	$49.0M
EPS	$2.24	$3.24	$0.63	$-0.46	$0.86
Op Margin	24.9%	28.0%	7.5%	-5.5%	8.1%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$2.4B	$2.5B	$2.8B	$2.8B	$3.0B
Total Liabilities	$608.0M	$621.0M	$866.0M	$857.0M	$844.0M
Cash	$604.0M	$523.0M	$751.0M	$757.0M	$566.0M
Borrowings	$366.0M	$423.0M	$712.0M	$686.0M	$690.0M

Latest News

Sector Update: Healthcare Stocks Softer Late Afternoon MT Newswires · Jul 22, 2026 Repligen to Buy BioLife Solutions for $1.5 Billion, Expanding Cell Therapy Reach MarketBeat · Jul 22, 2026 Sector Update: Healthcare Stocks Lower in Afternoon Trading MT Newswires · Jul 22, 2026 Top Midday Stories: Trump Threatens Retaliation for Attacks in Strait of Hormuz; AMD to Supply MI450 GPUs to Anthropic MT Newswires · Jul 22, 2026 Sector Update: Healthcare Stocks Edge Higher Premarket Wednesday MT Newswires · Jul 22, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$119.0M	$172.0M	$114.0M	$175.0M	$117.0M
Investing Cash Flow	$-288.0M	$-367.0M	$-162.0M	$-119.0M	$-322.0M
Financing Cash Flow	$-3.0M	$-17.0M	$-41.0M	$-17.0M	$-18.0M
Net Cash Flow	$-113.0M	$-80.0M	$228.0M	$6.0M	$-191.0M
Free Cash Flow	$52.0M	$39.0M	$75.0M	$142.0M	$94.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	2.06
EV / EBITDA	54.15
FCF Yield	1.39%
Quick Ratio	7.78
Interest Coverage	2.61
Return 1Y	19.33%
Return 3Y	-21.87%
Return 5Y	-33.50%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ATR	$136.77	+2.10%	19.32	$8.73B	1.66%
AVTR	$13.36	-2.34%	-9.79	$9.04B	0.00%
BAXBaxter International Inc.	$23.18	+3.46%	11.25	$11.97B	0.88%
BIO	$330.54	+4.47%	10.29	$8.94B	0.00%
CRL	$232.51	-0.90%	-54.59	$11.20B	0.00%

About RGEN

RGEN is led by CEO Olivier Loeillot, employs 2,000 people, headquartered in Waltham, US, publicly traded since 1986.

RGEN stock trades at $131.06 with a market capitalization of $7.39B. The stock is valued at a price-to-earnings (P/E) ratio of 145.51, price-to-book of 3.55, price-to-sales of 9.79. Over the past 52 weeks the stock has ranged between $100.99 and $175.77, and currently trades 25.4% below its 52-week high.

On profitability, RGEN generates a return on equity (ROE) of 2.51%, return on capital employed of 2.85%, an operating margin of 8.81%, a net profit margin of 6.73%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks Nasdaq High ROE Stocks All stock screens

Run Stock Screener Investing Guides